Press Releases Filter Filter Results Year 2024 (4) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) February 17, 2021 Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors January 29, 2021 Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5® with SmartAssist® January 28, 2021 Abiomed Announces Q3 FY 2021 Record Revenue of $232 Million, up 5% Year Over Year, With 31% Operating Margin January 7, 2021 Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents December 29, 2020 Abiomed to Present at the 39th Annual J.P. Morgan Healthcare Conference December 21, 2020 First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology December 15, 2020 Two Milestones Achieved Toward Small Bore Access with Impella® November 25, 2020 Abiomed to Hold Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference November 11, 2020 Abiomed to Hold Fireside Chat at the Stephens Annual Investment Conference 2020 November 5, 2020 First 1,000 Patients Treated with Impella 5.5® with SmartAssist®, a Heart Pump Designed for Surgeons October 29, 2020 Abiomed Announces Q2 FY 2021 Revenue of $210 Million, Up 27% Over Q1 FY 2021 and Up 2% Over Q2 FY 2020 With 29.2% Operating Margin October 28, 2020 First Patients Treated with the World’s Smallest Heart Pump, the 9Fr Impella ECP October 26, 2020 FDA Grants 510(k) Clearance for Abiomed’s Innovative Cardiopulmonary Support Technology October 16, 2020 Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Cardiogenic Shock is Associated with Higher Survival, Particularly in Women October 16, 2020 Studies Presented at TCT Connect Associate Higher Survival With Early Identification of Right Heart Failure and Early Use of Impella RP … 3 4 5 6 …
